Human Papilloma Virus Testing Knowledge and Attitudes Among Women Attending Colposcopy Clinic with ASCUS/LGSIL Pap Smears

Journal of Obstetrics and Gynaecology Canada

Volumn 26, Issue 9, 2004, Pages 788-792

  Le, T ^a   Hick, W ^a   Menard, C ^a   Boyd, D ^a   Hewson, T ^a   Hopkins, L ^a   Fung, M Fung Kee ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Carcinoma; Human; Papillomavirus; Patient education; Prevention and control; Squamous cell

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ATTITUDE TO HEALTH; CANADA; CLINICAL EVALUATION; COLPOSCOPY; CONTRACEPTION; DEMOGRAPHY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; EXPLORATORY RESEARCH; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL HISTORY; NEEDS ASSESSMENT; NURSING STAFF; OFFICE WORKER; PAPANICOLAOU TEST; PARITY; PREGNANCY; SMOKING; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; ADOLESCENT; MIDDLE AGED; PAPILLOMA VIRUS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COLPOSCOPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 21644465239     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30149-9     Document Type: Article

References (22)

1. Van der Graaf Y, Molijn A, Doornewaard H, Quint W, van Doom LJ, van den Tweel J Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 2002, 156:158-164.
2. Wright TC, Schiffman M Adding a test for human papilloma virus DNA to cervical cancer screening. N Engl J Med 2003, 348:489-490.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papilloma virus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
4. Cuzick J, Sasieni P, Davies P, Adams J, Normand C, Frater A, et al. A systematic review of the role of Human Papillomavirus testing within a cervical screening programme. Health Technol Assess 1999, 3:1-196.
5. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993, 85:958-964.
6. Brisson J, Morin C, Fortier M, Roy M, Bouchard C, Leclerc J, et al. Risk factors for cervical intraepithelial neoplasia: differences between low-and high-grade lesions. Am J Epidemiol 1994, 140:700-710.
7. Schlecht NF, Piatt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 2003, 95:1336-1343.
8. Tarkowski TA, Koumans EH, Sawyer M, Pierce A, Black CM, Papp JR, et al. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis 2004, 189:46-50.
9. Result of a randomized trial on the managementof cytologic interpretation of atypical squamous cell of undetermined significance. Am J Obstet Gynecol 2003, 188:1381-1392. ALTS group.
10. Human papillomaviruses. In: IARC monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC Sci Publications 2004, 64:212-231. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
11. Meerding WJ, van Ballegooijen M, Burger MP van den Akker-van Marie ME, Quint WG, Habbema JD. Human papillomavirus testing for triage of women referred because of abnormal smears, a decision analysis considering outcomes and costs. J Clin Epidemiol 2002, 55:1025-1032.
12. Gamzu R, Almog B, Levin I, Fainaru O, Niv J, Lessing JB, et al. Clinical and economic implications of adding HPV tests to the routine cytology follow-up and management of patients with histologically defined cervical intraepithelial neoplasia grade I. Gynecol Oncol 2002, 86:129-133.
13. Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 2002, 287:2372-2381.
14. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J Awareness of human papillomavirus among women attending a well woman clinic. SexTransm Infect 2003, 79:320-322.
15. Dell DL, Chen H, Ahmad F, Stewart DE Knowledge about human papillomavirus among adolescents. Obstet Gynecol 2000, 96(5 Pt I):653-656.
16. McKee MD, Caban A, Burton W, Mulvihill M Women's knowledge and experience of atypical Pap results in a high risk community. Women Health 2002, 36:19-31.
17. Philips Z, Johnson S, Avis M, Whynes DK Human papillomavirus and the value of screening: young women's knowledge of cervical cancer. Health Educ Res 2003, 18:318-328. Jun.
18. Byrom J, Clarke T, Neale J, Dunn PD, Hughes GM, Redman CW, et al. Can pre-colposcopy sessions reduce anxiety at the time of colposcopy? A prospective randomised study. J Obstet Gynaecol 2002, 22:415-420.
19. Ferris DG, Kriegel D, Cote L, Litaker M, Woodward L Women's triage and management preferences for cervical cytologic reports demonstrating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions. Arch Fam Med 1997, 6:348-353.
20. Cuzick J, Sasieni P, Davies P, Adams J, Normand C, Frater A, et al. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer 2000, 83:561-565.
21. Ramirez JE, Ramos DM, Clayton L, Kanowitz S, Moscicki AB Genital human papillomavirus infections: knowledge, perception of risk, and actual risk in a nonclinic population of young women. J Womens Health 1997, 6:113-121.
22. McCaffery K, Forrest S, Waller J, Desai M Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK. Br J Cancer 2003, 88:42-46.